OPTICYTE Trademark

Trademark Overview


On Monday, June 29, 2020, a trademark application was filed for OPTICYTE with the United States Patent and Trademark Office. The USPTO has given the OPTICYTE trademark a serial number of 90025742. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by Merakris Therapeutics, LLC. The OPTICYTE trademark is filed in the Pharmaceutical Products category with the following description:

Human biological amniotic membrane or other postpartum tissues intended for subsequent implantation; human biological amniotic tissue or other postpartum tissues that may include amniotic membrane, amniotic fluid, umbilical cord, or placenta, intended for medical use for the treatment or prevention of ophthalmic diseases, or the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; human biological tissue, namely, placental-derived tissue for use in biological tissue grafts for use in surgery and wound repair involving the eye; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye, and the treatment or prevention of ophthalmic diseases; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; topical treatment made from amniotic...
opticyte

General Information


Serial Number90025742
Word MarkOPTICYTE
Filing DateMonday, June 29, 2020
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6256450
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements


Goods and ServicesHuman biological amniotic membrane or other postpartum tissues intended for subsequent implantation; human biological amniotic tissue or other postpartum tissues that may include amniotic membrane, amniotic fluid, umbilical cord, or placenta, intended for medical use for the treatment or prevention of ophthalmic diseases, or the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; human biological tissue, namely, placental-derived tissue for use in biological tissue grafts for use in surgery and wound repair involving the eye; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye, and the treatment or prevention of ophthalmic diseases; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; wound treatment in the nature of amniotic material prepared in sheet forms or viscous forms

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 25, 2020
Primary Code005
First Use Anywhere DateFriday, August 18, 2017
First Use In Commerce DateTuesday, May 5, 2020

Trademark Owner History


Party NameMERAKRIS THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRESEARCH TRIANGLE PARK, NC 27709

Party NameMerakris Therapeutics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressResearch Triangle Park, NC 27709

Party NameMerakris Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressResearch Triangle Park, NC 27709

Party NameMerakris Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressResearch Triangle Park, NC 27709

Trademark Events


Event DateEvent Description
Wednesday, January 25, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 30, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 30, 2020ASSIGNED TO EXAMINER
Saturday, July 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 2, 2020NEW APPLICATION ENTERED